Skip to main content
OpenTrials

Clinical trial condition

Myelofibrosis

Explore clinical trials studying Myelofibrosis. Study availability and eligibility vary by location and protocol.

173 public trials 47 recruiting studies
Refine in advanced search Browse all conditions

Myelofibrosis trial results

Completed

Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in the Treatment of Myelofibrosis With Myeloid Metaplasia

NCT00360035

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • James A. Haley Veterans Hospital Tampa, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • The University of Chicago Chicago, Illinois, United States
View Trial Details
Completed

A Phase 1/2 Study of Oral SB1518 in Subjects With Chronic Idiopathic Myelofibrosis

NCT00745550

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +14 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Peter MacCallum Cancer Centre Melbourne, Victoria, Australia
View Trial Details
Completed

Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload

NCT00235391

Conditions
Anemia, Anemia, Aplastic, Anemia, Diamond-Blackfan, +19 more
Locations
  • Arkansas Children's Hospital, UAMS College of Medicine Little Rock, Arkansas, United States
  • Alta Bates Comprehensive Cancer Center Berkeley, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Children's Hospital and Health Center of San Diego San Diego, California, United States
View all 141 locations
View Trial Details
Completed

A Dose-escalation Study of the Safety and Tolerability of Orally Administered TG101348 in Patients With Myelofibrosis

NCT00631462

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • UCSD Moores Cancer Center San Diego, California, United States
  • Stanford Comprehensive Cancer Center Stanford, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
View Trial Details
Completed

Bone Marrow Transplant Chart Review for RIC

NCT00723333

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Baylor College of Medicine Houston, Texas, United States
  • M.D. Anderson Cancer Centers Houston, Texas, United States
  • University of Utah Salt Lake City, Utah, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
View Trial Details

Related conditions